2021 CMSC Annual Meeting

VIRAL INFECTIONS IN MS: WHAT HAVE WE LEARNED FROM COVID-19

CREDITS: APA, CME, CNE, CPE, OT, PA, RD, SW
Expiration: 30-Apr-22
Level of Information: Intermediate, Advanced

This program is designed to address multiple topics germane to the COVID-19 pandemic and multiple sclerosis. The program will begin with an overview of the potential role of viruses in the pathogenesis of MS and their contributions to MS exacerbations by Dr. Kottil Rammohan. A general overview of SARS-CoV2 infection and associated neurological disorders with particular attention to demyelinating autoimmune disorders triggered by the virus will be given by Dr. Joseph Berger. The effect of the virus on the course of MS and the effect of disease modifying therapies on the course of COVID-19 will be addressed by Dr. Anne Cross. A discussion of the effects of DMTs on vaccine response will be provided by Dr. Amit Bar-Or. Question and answer sessions will follow each discussion.

Presentations and Speakers

Introduction Joseph Berger, MD
Viral Disease and MS – General Overview Kottil Rammohan, MD
COVID 19 – The Virus, Its Clinical Manifestations and Neurological Complications Joseph Berger, MD
The Effect of COVID-19 on MS and the Effect of DMTs on COVID-19 Anne H. Cross, MD Vaccinations and DMTs Amit Bar-Or, MD, FRCPC
Q & A Panel

You can only claim credits for this On-demand Video if you have not done so for the Live Event.